Showing 341 - 360 of 1706 results
The Australian Government recently signed a landmark emissions reduction technology deal with Great Britain, which includes nuclear energy and clean hydrogen among the six key low emission technologies the two countries hope to advance.
A team of scientists led by Monash University and the University of Melbourne in association with the Peter Doherty Institute for Infection and Immunity have made progress in clarifying the molecular interactions that underpin how our adaptive immune cells recognise SARS CoV-2, which causes COVID-19.
The National Deuteration Facility is providing deuterated cholesterol, an essential ingredient in lipid nanoparticles for the delivery of vaccines using mRNA, to academic and industry partners.
During the scheduled shutdown of the OPAL multi-purpose reactor, an ANSTO engineering and project team has installed a new safety shutdown instrumentation and control system (I&C).
ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program
ANSTO scientists will contribute to a new $1 million ARC Linkage Project grant to evaluate human responses to post glacial sea level rise at Red Lily, Arnhem land led by Griffith University.
PNG researcher provides a progress update on an aquaculture project to improve the industry and benefit the local population
Professor Peter Lay from the University of Sydney has been awarded the Australian Synchrotron Lifetime Contribution Award by ANSTO, the Australian Nuclear Science and Technology Organisation.
A large collaboration of European investigators gained insights into how the SARS-CoV-2 spike protein (S protein) impacts with lipid metabolism in the body with implications for COVID-19 infection and mRNA vaccination.